Silverarc Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
86,552
+10,801
| +14% | +$1.86M | 2.75% | 13 |
|
|
2025
Q1 | $11.8M | Buy |
75,751
+24,260
| +47% | +$3.78M | 2.41% | 13 |
|
|
2024
Q4 | $7.09M | Buy |
51,491
+46,491
| +930% | +$6.4M | 1.55% | 22 |
|
|
2024
Q3 | $747K | Buy |
+5,000
| New | +$747K | 0.17% | 60 |
|
|
2023
Q1 | – | Sell |
-23,151
| Closed | -$2.83M | – | 69 |
|
|
2022
Q4 | $2.83M | Buy |
23,151
+18,151
| +363% | +$2.22M | 0.81% | 38 |
|
|
2022
Q3 | $516K | Buy |
+5,000
| New | +$516K | 0.17% | 60 |
|
|
2022
Q2 | – | Sell |
-25,000
| Closed | -$1.43K | – | 62 |
|
|
2022
Q1 | $1.43K | Buy |
+25,000
| New | +$1.43K | 0.59% | 40 |
|
|
2021
Q3 | – | Sell |
-5,599
| Closed | -$737 | – | 84 |
|
|
2021
Q2 | $737 | Sell |
5,599
-13,095
| -70% | -$1.72K | 0.33% | 67 |
|
|
2021
Q1 | $2.41M | Buy |
18,694
+1,138
| +6% | +$147K | 1.31% | 28 |
|
|
2020
Q4 | $2.93M | Buy |
+17,556
| New | +$2.93M | 1.7% | 20 |
|